Retrovirus vectors: toward the plentivirus?

Molecular Therapy : the Journal of the American Society of Gene Therapy
Christopher BaumMelanie Galla

Abstract

Recombinant retroviral vectors based upon simple gammaretroviruses, complex lentiviruses, or potentially nonpathogenic spumaviruses represent relatively well characterized tools that are widely used for stable gene transfer. Different members of the Retroviridae family have developed distinct and potentially useful features related to their life cycle. These natural differences can be exploited for specialized applications in gene therapy and could conceivably be combined to create future retroviral hybrid vectors, ideally incorporating the following features: an efficient, noncytopathic packaging system with low likelihood of recombination; serum resistance; an ability to pseudotype with cell-specific envelopes; high-fidelity reverse transcription before cell entry; unrestricted cytoplasmic transport and nuclear import; an insulated expression cassette; specific chromosomal targeting; and physiologic or regulated levels of transgene expression. We envisage that, compared to contemporary vectors, a hybrid vector combining these properties would have increased therapeutic efficacy and an enhanced biosafety profile. Many of the above goals will require the inclusion of nonretroviral components into vector particles or transgenes.

References

Oct 1, 1992·The Journal of Experimental Medicine·R E DonahueR Moen
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M I BukrinskyM Stevenson
Jan 1, 1990·Human Gene Therapy·A D Miller
May 1, 1990·Journal of Medical Virology·J M Coffin
Jul 8, 1987·Biochimica Et Biophysica Acta·S P Goff, L I Lobel
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S F YuE Gilboa
May 14, 1993·Science·R C Mulligan
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·J EnssleA Rethwilm
May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·C MünkC Stocking
Jan 19, 1999·Annual Review of Microbiology·V W Pollard, M H Malim
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·T KafriI M Verma
Feb 24, 2001·The Journal of Gene Medicine·J C Zhao-EmonetD Klatzmann
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·A LoonstraJ Jonkers
Aug 15, 2001·Antimicrobial Agents and Chemotherapy·K LindstenN P Dantuma
Oct 6, 2001·Current Opinion in Microbiology·M D Miller, D J Hazuda
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexander PfeiferInder M Verma
Feb 28, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elisa VignaLuigi Naldini
Apr 19, 2002·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Apr 20, 2002·Science·Zhixiong LiChristopher Baum
Jun 20, 2002·Journal of Virology·Anne-Kathrin ZaissLung-Ji Chang
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Sep 17, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Grant TrobridgeDavid W Russell
Dec 3, 2002·Current Opinion in Biotechnology·Aaron C LoganDonald B Kohn
Jan 4, 2003·Blood·Christopher BaumChristof von Kalle

❮ Previous
Next ❯

Citations

Dec 21, 2013·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Arthur A HurwitzZiqiang Zhu
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christine VoelkelChristopher Baum
Apr 24, 2010·Expert Reviews in Molecular Medicine·Vsevolod V Gurevich, Eugenia V Gurevich
Nov 16, 2010·Virology Journal·Dimple Khetawat, Christopher C Broder
Oct 14, 2011·Viruses·Tobias MaetzigAxel Schambach
Feb 22, 2012·PloS One·Lakshmikanth MariyannaJoachim Hauber
Jan 18, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alex H Chang, Michel Sadelain
Jan 25, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Charlotte DalbaDavid Klatzmann
Nov 14, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tatjana I Cornu, Toni Cathomen
Nov 30, 2007·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·C BaumA Thrasher
Oct 19, 2010·Nature Methods·Morag H StewartMickie Bhatia
Jan 25, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Dirk M Nettelbeck
Apr 21, 2011·Expert Review of Anti-infective Therapy·Jean-Michel Garcia, Jimmy C C Lai
Aug 21, 2007·Expert Opinion on Biological Therapy·Sharyn ThomasHans J Stauss
Jun 15, 2011·Trends in Biotechnology·Tristen S ParkRichard A Morgan
Mar 30, 2011·Advanced Drug Delivery Reviews·Yasufumi Kaneda
Sep 28, 2010·Advanced Drug Delivery Reviews·Christopher B DoeringH Trent Spencer
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Oct 4, 2015·Current Opinion in Pharmacology·Juliane W SchottAxel Schambach
Mar 3, 2015·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Juliane W SchottAxel Schambach
Jun 24, 2011·Pharmazie in unserer Zeit·Christopher Baum
Oct 23, 2009·Gene Therapy·M B Banasik, P B McCray
Apr 19, 2013·Clinical and Experimental Vaccine Research·Jae-Min SongBaik-Lin Seong
May 26, 2017·Biomedicines·Richard A Morgan, Benjamin Boyerinas
Aug 10, 2013·Molecular Cancer Research : MCR·Marco RanzaniEugenio Montini
Mar 19, 2021·International Immunopharmacology·Namrata M Nilavar, Sathees C Raghavan
Jun 27, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adrian SchwarzerMichael Rothe
Oct 21, 2021·Biology of Reproduction·Nima DehdilaniHesam Dehghani

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Perry B HackettLaurence J N Cooper
© 2022 Meta ULC. All rights reserved